Study: Melioidosis Underreported

Researchers warn that a poorly understood, life-threatening tropical disease may be killing thousands more people than previously realized.

Written byCatherine Offord
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Burkholderia pseudomallei growing on agarWIKIMEDIA, GAVIN KOHThe bacterium that causes melioidosis—an obscure but deadly infectious disease—may be present in as many 79 countries around the world and could be responsible for nearly 90,000 deaths each year, according to a study published yesterday (January 11) in Nature Microbiology.

Burkholderia pseudomallei was previously thought to be confined mainly to Southeast Asia and Australia, where the disease has reported fatality rates of between 20 percent and 50 percent. But using the locations of over 22,000 reported human and animal cases to construct a statistical model, researchers from the University of Oxford predicted that melioidosis is underreported in 45 countries where it is known to be present, and endemic in a further 34 where it has never been reported.

“Although melioidosis has been recognized for more than 100 years, awareness of it is still low, even among medical and laboratory staff in confirmed endemic areas,” coauthor Direk Limmathurotsakul of the University of Oxford and Mahidol University, Thailand, said in a press release. “Melioidosis is a great ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • After undergraduate research with spiders at the University of Oxford and graduate research with ants at Princeton University, Catherine left arthropods and academia to become a science journalist. She has worked in various guises at The Scientist since 2016. As Senior Editor, she wrote articles for the online and print publications, and edited the magazine’s Notebook, Careers, and Bio Business sections. She reports on subjects ranging from cellular and molecular biology to research misconduct and science policy. Find more of her work at her website.

    View Full Profile
Share
Illustration of a developing fetus surrounded by a clear fluid with a subtle yellow tinge, representing amniotic fluid.
January 2026

What Is the Amniotic Fluid Composed of?

The liquid world of fetal development provides a rich source of nutrition and protection tailored to meet the needs of the growing fetus.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies

Parse Logo

Parse Biosciences and Graph Therapeutics Partner to Build Large Functional Immune Perturbation Atlas

Sino Biological Logo

Sino Biological's Launch of SwiftFluo® TR-FRET Kits Pioneers a New Era in High-Throughout Kinase Inhibitor Screening

SPT Labtech Logo

SPT Labtech enables automated Twist Bioscience NGS library preparation workflows on SPT's firefly platform